MedTrace Logo

Default Options in Advance Directives

NCT02017548 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2019-04-01

No results posted yet for this study

Summary

In a multicenter, randomized clinical trial of default options in advance directives among patients with incurable diseases, we will determine whether this simple and readily scalable intervention can improve patients quality of life and reduce resource utilization without reducing the number of days that patients are alive and living outside of an acute-care hospital.

Conditions

  • This Study Will Focus on Advance Care Planning Among Patients With Life-limiting Illnesses

Interventions

BEHAVIORAL

Life-extension default advance directive

BEHAVIORAL

Comfort default advance directive

Sponsors & Collaborators

Principal Investigators

  • Scott D. Halpern, MD, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017548 on ClinicalTrials.gov